Home/Filings/4/0001209191-16-117514
4//SEC Filing

BG Medicine, Inc. 4

Accession 0001209191-16-117514

CIK 0001407038operating

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:15 PM ET

Size

7.2 KB

Accession

0001209191-16-117514

Insider Transaction Report

Form 4
Period: 2014-04-14
Adourian Aram S.
VP, Scientific Affairs
Transactions
  • Exercise/Conversion

    Common Stock

    2014-04-14$0.90/sh+12,000$10,80040,036 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-04-1412,00016,036 total
    Exercise: $0.90Exp: 2014-04-15Common Stock (12,000 underlying)
Footnotes (2)
  • [F1]The reporting person paid cash for the exercise price. The share and exercise price figures in this report do not reflect the 1-for-4 reverse stock split of the issuer's common stock effected on July 8, 2015.
  • [F2]All of the shares underlying this option were vested and the option expired on April 15, 2014.

Issuer

BG Medicine, Inc.

CIK 0001407038

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001407038

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:15 PM ET
Size
7.2 KB